Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia - PubMed

Affiliations

• PMID: 12406866
• DOI: 10.1182/blood-2002-07-2006

Free article

Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia

Mario Cazzola et al. Blood. 2003.

Free article

Abstract

The sideroblastic anemias are characterized by ring sideroblasts, that is, red cell precursors with mitochondrial iron accumulation. We therefore studied the expression of mitochondrial ferritin (MtF) in these conditions. Erythroid cells from 13 patients with refractory anemia with ring sideroblasts (RARS) and 3 patients with X-linked sideroblastic anemia (XLSA) were analyzed for the distribution of cytoplasmic H ferritin (HF) and MtF using immunocytochemical methods. We also studied 11 healthy controls, 5 patients with refractory anemia without ring sideroblasts (RA), and 7 patients with RA with excess of blasts (RAEB). About one fourth of normal immature red cells, mostly proerythroblasts and basophilic erythroblasts, showed diffuse cytoplasmic positivity for HF, but very few were positive for MtF (0%-10%). Similar patterns were found in anemic patients without ring sideroblasts. In contrast, many erythroblasts from patients with sideroblastic anemia (82%-90% in XLSA and 36%-84% in RARS) were positive for MtF, which regularly appeared as granules ringing the nucleus. Double immunocytochemical staining confirmed the different cellular distribution of HF and MtF. There was a highly significant relationship between the percentage of MtF(+) erythroblasts and that of ring sideroblasts (Spearman R = 0.90; P <.0001). Reverse transcription-polymerase chain reaction studies demonstrated the presence of MtF mRNA in circulating reticulocytes of 2 patients with XLSA but not in controls. These findings suggest that most of the iron deposited in perinuclear mitochondria of ring sideroblasts is present in the form of MtF and that this latter might be a specific marker of sideroblastic anemia.

Similar articles

• Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.

  Tehranchi R, Invernizzi R, Grandien A, Zhivotovsky B, Fadeel B, Forsblom AM, Travaglino E, Samuelsson J, Hast R, Nilsson L, Cazzola M, Wibom R, Hellström-Lindberg E. Tehranchi R, et al. Blood. 2005 Jul 1;106(1):247-53. doi: 10.1182/blood-2004-12-4649. Epub 2005 Mar 8. Blood. 2005. PMID: 15755901

• Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation.

  Saito K, Fujiwara T, Hatta S, Morita M, Ono K, Suzuki C, Fukuhara N, Onishi Y, Nakamura Y, Kawamata S, Shimizu R, Yamamoto M, Harigae H. Saito K, et al. Mol Cell Biol. 2019 Mar 19;39(7):e00387-18. doi: 10.1128/MCB.00387-18. Print 2019 Apr 1. Mol Cell Biol. 2019. PMID: 30670569 Free PMC article.

• The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.

  Boultwood J, Pellagatti A, Nikpour M, Pushkaran B, Fidler C, Cattan H, Littlewood TJ, Malcovati L, Della Porta MG, Jädersten M, Killick S, Giagounidis A, Bowen D, Hellström-Lindberg E, Cazzola M, Wainscoat JS. Boultwood J, et al. PLoS One. 2008 Apr 9;3(4):e1970. doi: 10.1371/journal.pone.0001970. PLoS One. 2008. PMID: 18398482 Free PMC article.

• Refractory anemia with ring sideroblasts.

  Malcovati L, Cazzola M. Malcovati L, et al. Best Pract Res Clin Haematol. 2013 Dec;26(4):377-85. doi: 10.1016/j.beha.2013.09.005. Epub 2013 Oct 1. Best Pract Res Clin Haematol. 2013. PMID: 24507814 Review.

• Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management".

  Patnaik MM, Tefferi A. Patnaik MM, et al. Am J Hematol. 2019 Apr;94(4):475-488. doi: 10.1002/ajh.25397. Epub 2019 Jan 24. Am J Hematol. 2019. PMID: 30618061 Free PMC article. Review.

Cited by

• Importance of classical morphology in the diagnosis of myelodysplastic syndrome.

  Invernizzi R, Quaglia F, Porta MG. Invernizzi R, et al. Mediterr J Hematol Infect Dis. 2015 May 1;7(1):e2015035. doi: 10.4084/MJHID.2015.035. eCollection 2015. Mediterr J Hematol Infect Dis. 2015. PMID: 25960863 Free PMC article. Review.

• Uncoupling of CD71 shedding with mitochondrial clearance in reticulocytes in a subset of myelodysplastic syndromes.

  Zhang Q, Steensma DP, Yang J, Dong T, Wu MX. Zhang Q, et al. Leukemia. 2019 Jan;33(1):217-229. doi: 10.1038/s41375-018-0204-z. Epub 2018 Jul 26. Leukemia. 2019. PMID: 30050123 Free PMC article.

• Mitochondrial Ferritin Protects Hydrogen Peroxide-Induced Neuronal Cell Damage.

  Gao G, Zhang N, Wang YQ, Wu Q, Yu P, Shi ZH, Duan XL, Zhao BL, Wu WS, Chang YZ. Gao G, et al. Aging Dis. 2017 Jul 21;8(4):458-470. doi: 10.14336/AD.2016.1108. eCollection 2017 Jul. Aging Dis. 2017. PMID: 28840060 Free PMC article.

• Characterization of human mitochondrial ferritin promoter: identification of transcription factors and evidences of epigenetic control.

  Guaraldo M, Santambrogio P, Rovelli E, Di Savino A, Saglio G, Cittaro D, Roetto A, Levi S. Guaraldo M, et al. Sci Rep. 2016 Sep 14;6:33432. doi: 10.1038/srep33432. Sci Rep. 2016. PMID: 27625068 Free PMC article.

• The hydrogenase-like Nar1p is essential for maturation of cytosolic and nuclear iron-sulphur proteins.

  Balk J, Pierik AJ, Netz DJ, Mühlenhoff U, Lill R. Balk J, et al. EMBO J. 2004 May 19;23(10):2105-15. doi: 10.1038/sj.emboj.7600216. Epub 2004 Apr 22. EMBO J. 2004. PMID: 15103330 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal